My bioparkWELCOME TO BIOPARK
What's in
the news ?
RUE AUGUSTE PICCARD, 48 AÉROPOLE DE CHARLEROI B-6041 CHARLEROI
+32 71 91 99 50
Events
Coolerr Bags Information
August 15th - 16th 2019
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, announced that clinical data from the ongoing phase 2a study of its lead product candidate HepaStem ® in patients with Acute-on-Chronic Liver Failure. Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, announced that clinical data from the ongoing phase 2a study of its lead product candidate HepaStem ® in patients with Acute-on-Chronic Liver Failure. Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, announced that clinical data from the ongoing phase 2a study of its lead product candidate HepaStem ® in patients with Acute-on-Chronic Liver Failure.